Search For "drugs controller"
Zydus Cadila vaccine to be inoculated through applicator, not injection, s
Updated : 4 years, 5 months ago IST
New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller General of India (DGCI) for emergency use, Dr VK Paul, Member (Health) of Niti Aayog on Thursday said that the vaccine will be administered through an applicator which will be us
Read More
Priority will be children with comorbidities in paediatric COVID vaccine d
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
Read More
More scientific data required on mixing of COVID-19 vaccine doses: Secreta
Updated : 4 years, 6 months ago IST
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
Read More
Adolescents likely to get ZyCoV-D COVID vaccine after four weeks
Updated : 4 years, 7 months ago IST
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.
Read More
India approves Zydus Cadila's ZyCoV-D vaccine for emergency use for adults
Updated : 4 years, 7 months ago IST
New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
Read More
Johnson and Johnson still in discussion with Centre over indemnity issue:
Updated : 4 years, 7 months ago IST
New Delhi [India], August 2 (ANI): The US-based pharmaceutical company Johnson and Johnson is still in talks with the Centre over its COVID-19 vaccine, said sources on Monday.
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 8 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DC
Updated : 4 years, 8 months ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More
DCGI examining Zydus Cadila's COVID vaccine for children, says Dr VK Paul
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 8 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Johnson & Johnson won't be conducting COVID-19 vaccine trials in India
Updated : 4 years, 9 months ago IST
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday.
Read More